Laboratory Evaluation of Coagulation and Fibrinolysis Flashcards
Things to consider:
- Tissue thromboplastin contamination
- Inappropriate container
- Improper temperature: labile factors
- Hemolysis
Inappropriate container
a) Glass surface
b) Polystyrene tubes/ glass tube with silicone- preferred
- preferred
Polystyrene tubes/ glass tube with silicone
@room temp: _______
V & VIII
@ref temp: _________
VII & XI
PT plasma capped stability for 24 hours @: _____
RT (18-24oC)
APTT samples stable for 4 hours @: ___________
RT (18-24oC)
Factor assays stable for 4 hours @: ___________
RT (18-24oC)
Hemolysis
-prolonged tourniquet application
-moisture/contamination
-inappropriate needle bore
-Frothing of sample
-improper transfer from barrel to tube
-excessive mixing mixing
▪ Adult (≤25 mL):
G20 -21; 1 - 1.25 in.
▪ Adult (≥25 mL):
G19; 1 or 1.25 in.
▪ Child or adult with small, friable, or hardened veins:
G23
▪ Syringe w/ winged-needle set:
G20, 21, or 23 (mostly)
: used in blood donations
▪ G16-18
Type of Syringe:
Plastic/Silicone coated- single draw
2-way needle and holder-multiple draw
Winged-needle sets
Anticoagulants:
A) Sodium oxalate
B) Trisodium citrate
4) Heparin
3) EDTA
: Interfere with Spectrophotometric reading (OD)
A) Sodium oxalate
: -Preserves FV and FVIII
B) Trisodium citrate
- Ratio of 9:1 (blood: anticoagulant)
B) Trisodium citrate
B) Trisodium citrate Prolonged
- Incomplete filling/high hematocrit
B) Trisodium citrate
- Two concentrations:
3.2% and 3.8%
-acts with antithrombin III to inhibit all stages of coagulation
4) Heparin:
-used for plt retention test
4) Heparin:
-unsuitable for coagulation
3) EDTA
-inhibits thrombin-fibrinogen reaction
3) EDTA
-Factor V is unstable in its presence
3) EDTA
Evacuated tube arrangement: 2-way needle collection
a. Red stopper
b. Blue stopper (3.2%)
c. Lavander stopper
d. plastic syringe (for additional tests)
1) Effects of pH: _______
PROLONG THE CT
2) Temperature: (as mentioned during the first slide)
PPP preparation: __________ for _________
2000 x g for 10 mins
Storage: 4 deg within 2 hours/ rapid freezing @:_______________
-20oC
PRP preparation: __________ for________@___
60-100 x g for 10 mins @ RT
Principle: when venous blood is put into a glass tube, it will form a solid clot.
Lee and White Method
-the time response is a measure of overall intrinsic and common pathway
Lee and White Method
-Insensitive to factor deficiencies.
Lee and White Method
Lee and White Method NV:
7-15 mins
Principle: Presence of an activator (DIATOME) and by keeping the blood constant at 37 deg celsius, the test is more reliable and rapid.
Activated Clotting Time
Activated Clotting Time NV:
75-120 sec.
Principle: Time required for blood to clot after the addition of calcium
Plasma Recalcification Time (PRT)
-Modified Lee and White
Plasma Recalcification Time (PRT)
Plasma Recalcification Time (PRT) NV:
PRP: 100-150 sec
PPP: 130-240 sec
Routine screening of coagulation disorders in intrinsic system and common pathway
Activated partial thromboplastic time (APTT/PTT)
- Detects the presence of circulating anti-coagulant
Activated partial thromboplastic time (APTT/PTT)
- Monitors heparin therapy
Activated partial thromboplastic time (APTT/PTT)
Principle: Measures all coagulation factors needed for the generation of Intrinsic prothrombinase except for Calcium and PPL
Activated partial thromboplastic time (APTT/PTT)
When Calcium is added with incomplete thromboplastin (plt substitute- CEPHALIN), intrinsic prothrombinase is generated.
Activated partial thromboplastic time (APTT/PTT)
Activated partial thromboplastic time (APTT/PTT) Specimen:
Citrated PPP
Activated partial thromboplastic time (APTT/PTT) Reagent:
0.025M CaCL2
Phospholipid (plt sub)
Activated partial thromboplastic time (APTT/PTT) Activators:
kaolin, celite or ellagic acid
Activated partial thromboplastic time (APTT/PTT) NV:
25-35 seconds/ 22-34 seconds
Prolonged PTT:
- Deficiency in intrinsic/common pathway factors
- Presence of inhibitor
- <60 mg/dL fibrinogen
- Increased FSP
-screening for the extrinsic and common pathway coagulation.
PROTHROMBIN TIME (Quick’s Test)
-monitors oral anticoagulant with COUMADIN
PROTHROMBIN TIME (Quick’s Test)
PROTHROMBIN TIME (Quick’s Test)
Principle: When tissue extract of (?) is added to (?), along with (?), it reacts with (?) to activate (?).
thromboplastin (complete)
PPP
Calcium
FVII
FX
PROTHROMBIN TIME (Quick’s Test) Sample:
Citrated PPP
PROTHROMBIN TIME (Quick’s Test) Reagents:
Thromboplastin 0.025M CaCL2
INR=
International Normalized Ratio
-standardized way of reporting PT in monitoring anticoagulant therapy
International Normalized Ratio
-calculated as a ratio of the px PT to a control PT (standardized for the potency of the thromboplastin rgt)
International Normalized Ratio
ISI=
International Sensitivity Index (calibration index)
Reference Values for INR
2.0-3.0
2.5-3.5
2.0-3.0
▪ in prevention and treatment of viscous thrombosis
▪ treatment of pulmonary embolism
▪ prevention of stroke in myocardial infarction
▪ peripheral arterial disease
▪ prevention of systemic embolism in atrial fibrillation
▪ cardia valve replacement (tissue valves)
2.5-3.5
▪ in prevention of recurrent MI
▪ reduction of mortality in MI
▪ mechanical prosthetic heart valve (high risk)
PROTHROMBIN TIME (Quick’s Test)
NV:
10-12 seconds
PROTHROMBIN TIME (Quick’s Test) Prolonged in:
-extrinsic and common pathway factor deficiencies
- Fibrinogen of <100 mg/dL
- Dysfibrinogenemia
- Vit K deficiency and certain liver disease
- Increased FDP’s
- False prolongation: heparin contamination
PROTHROMBIN TIME (Quick’s Test) Shortened in:
-Traumatic venipuncture
is a thromboplastin-like substance
Venom “Vipera ruselli”
STYPVEN/RUSELL’s VIPER VENOM
Principle: Addition of the (?) bypasses the activation of(?) and directly activates (?).
venom
VII
FX
STYPVEN/RUSELL’s VIPER VENOM NV:
6-10 seconds
What is the function of Dilute Russel Viper Venome time (dRVVT)?
Detects the presence of lupus anticoagulant
INDIRECT TESTS
Otherwise known as “Fibrinogen Deficiency Test”
THROMBIN TIME
THROMBIN TIME
Principle: Addition of thrombin bypasses all coagulation pathways except:
polymerization of Fibrinogen
.-measures the availability of functional fibrinogen
THROMBIN TIME
-measures the conversion of fibrinogen to fibrin
THROMBIN TIME
THROMBIN TIME NV:
17-25 seconds
Prolonged TT:
Fibrinogen level: 75-100 mg/dL
Impairment of fibrinogen
Presence of Heparin and FDP
Normally prolonged in newborn and multiple myeloma
REPTILASE TIME NV:
18-20 seconds
REPTILASE TIME Prolonged in:
Fibrinogen deficiency
Presence of FSP
Heparin Therapy; NF1 Prolonged
THROMBIN TIME
Heparin Therapy; NF1 Normal
REPTILASE TIME
FSP: NF1 Prolonged
THROMBIN TIME
REPTILASE TIME
Hypofibrinogenemia Greatly prolonged
THROMBIN TIME
Hypofibrinogenemia Prolonged
REPTILASE TIME
Dysfibrinogenemia Prolonged
THROMBIN TIME
Dysfibrinogenemia Greatly prolonged
REPTILASE TIME
Test for FXIII deficiency
DUKERT TEST (5M Urea Solubility Test)
DUKERT TEST (5M Urea Solubility Test)
Principle: clot formed in (?) is insoluble in (?) during a (?).
normal plasma
5M urea
24 hr incubation
Indicator: If Factor XIII is deficient, the clot is dissolved in less than 24 hours by urea
DUKERT TEST (5M Urea Solubility Test)
Clot + 5M Urea
NORMAL
FXIII Deficiency
Excessive fibrinolysis
Clot +NaCl
NORMAL
FXIII Deficiency
Excessive fibrinolysis
-screening procedure for the assessment of fibrinolysis
EUGLOBULIN TEST
-Euglobulin fraction:
Plasminogen, activators of plasminogen, fibrinogen
-EUGLOBULIN TEST
Principle: Plasma euglobulins are precipitated with (?). Precipitates are redissolved and clotted with (?). The clot is incubated and the time for complete lysis @ (?) is measured.
1 %Hac
thrombin
37 deg celcius
EUGLOBULIN TEST NV:
2-4 hours
: abnormal fibrinolytic activity
<2 hours
EUGLOBULIN TEST Increase fibrinolytic activity is seen on:
-circulatory collapse
-adrenalin injection
-sudden death
-pulmonary surgery
-pyrogen reaction
-obstetric complications
: Rapid clot breakdown
Primary
-increase in the circulating tPA binding to fibrin
Primary
-Excess tPA
Primary
-Excess tPA 2:
decreased hepatic clearance
decreased fibrinolytic inhibitors
Secondary: Secondary to
systemic hypercoagulability
-systemic or microvascular
Secondary
-not localized
Secondary
-commonly assoc with DIC
Secondary
-detects fibrin monomers
PROTAMINE SULFATE TEST and ETHANOL GELATION TEST